89 results
8-K
EX-3.1
PRPH
ProPhase Labs Inc
20 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
hold office until such director’s successor shall have been duly elected and qualified or until such director’s earlier death, resignation or removal … by the stockholders.
Section 8. VACANCIES IN THE BOARD OF DIRECTORS. Any vacancies in the Board of Directors resulting from death, resignation
8-K
EX-3.1
PRPH
ProPhase Labs Inc
20 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
duly elected and qualified or until such director’s earlier death, resignation or removal. Directors need not be stockholders.
Section 2. REGULAR … OF DIRECTORS. Any vacancies in the Board of Directors resulting from death, resignation, retirement, disqualification, removal from office or other cause
8-K
EX-10.2
PRPH
ProPhase Labs Inc
20 Jun 23
Departure of Directors or Certain Officers
4:15pm
the Participant’s death shall be distributed to the Participant’s designated beneficiary(ies) or, if none was designated, the Participant’s estate.
(iii) Share … exercisable after the death of a Participant may be exercised by the legatees, personal representatives or distributees of the Participant.
13
8-K
EX-10.1
PRPH
ProPhase Labs Inc
20 Jun 23
Departure of Directors or Certain Officers
4:15pm
after the Participant’s death shall be distributed to the Participant’s designated beneficiary(ies) or, if none was designated, the Participant’s … . An Award exercisable after the death of a Participant may be exercised by the legatees, personal representatives or distributees of the Participant.
13
8-K
EX-99.1
vsbs57a pk2irv7d
20 Dec 22
ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
8:30am
8-K
EX-10.1
sqnjvbtn97d0e
20 Dec 22
ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
8:30am
S-8
EX-99.1
xl7mgjbx3tlprx wqcf
14 Nov 22
Registration of securities for employees
5:03pm
8-K
EX-99.1
4o8ztlc6ey grfjkdos
28 Jun 22
ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology
8:35am
8-K
EX-10.1
f8bd2jwhy
13 Jun 22
ProPhase Labs Announces Significant Laboratory Expansion
9:32am
8-K
EX-10.2
pg6pnvvxscq qh
13 Jun 22
ProPhase Labs Announces Significant Laboratory Expansion
9:32am
8-K
EX-10.2
dfl1 8hq6r
20 May 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
r0a4h xe79irkmiidgdd
20 May 22
Departure of Directors or Certain Officers
4:05pm